Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase

被引:36
作者
Ratnikov, BI [1 ]
Deryugina, EI [1 ]
Strongin, AY [1 ]
机构
[1] Burnham Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1097/01.LAB.0000038555.67772.DB
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gelatin zymography is the common method for examining matrix metalloproteinase-2 (MMP-2) in cells and media samples. Activation of the latent MMP-2 zymogen involves its binding to the cell surface MT1 -MMP.TIMP-2 (membrane type-1 matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase-2) complex with subsequent cleavage of proMMP-2 by TIMP-2-free adjacent MT1-MMP. This is followed by autolytic maturation of the activation intermediate and the release of the mature MMP-2 species from cell surfaces into the extracellular milieu. To observe the MMP-2 activation pathway in more detail, proMMP-2-deficient MCF7 breast carcinoma cells expressing MT1 -MMP were incubated with excess proMMP-2 to saturate the available MT1 -MMP.TIMP-2 surface receptors. After removal of the unbound material, the kinetics of proMMP-2 activation and MMP-2 release from cells into media was monitored by gelatin zymography and substrate cleavage. Our observations demonstrate that gelatin zymography is insufficient for providing meaningful information about the status of MMP-2. The proteolytically competent mature MMP-2 moiety alone, but not in its complex with TIMP-2, was released from the cells. In tissue culture conditions, the enzyme's proteolytic activity was suppressed in the next 30 to 60 minutes by tissue inhibitors of MMPs, especially by TIMP-1. The picture emerges that there is a likely temporal regulation of MMP-2 activity by TIMPs in tumor cells. These relatively rapid changes of the MMP-2 status cannot be detected by gelatin zymography. Additional studies are needed to examine the significance of this phenomenon in vivo.
引用
收藏
页码:1583 / 1590
页数:8
相关论文
共 38 条
[1]   Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells [J].
Bassi, DE ;
De Cicco, RL ;
Mahloogi, H ;
Zucker, S ;
Thomas, G ;
Klein-Szanto, AJP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10326-10331
[2]  
Bigg HF, 2001, CANCER RES, V61, P3610
[3]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[4]   Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity [J].
Brooks, PC ;
Silletti, S ;
von Schalscha, TL ;
Friedlander, M ;
Cheresh, DA .
CELL, 1998, 92 (03) :391-400
[5]   MT1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells [J].
Deryugina, EI ;
Ratnikov, B ;
Monosov, E ;
Postnova, TI ;
DiScipio, R ;
Smith, JW ;
Strongin, AY .
EXPERIMENTAL CELL RESEARCH, 2001, 263 (02) :209-223
[6]  
Deryugina EI, 1997, J CELL SCI, V110, P2473
[7]  
Deryugina EI, 1998, CANCER RES, V58, P3743
[8]  
Deryugina EI, 1997, ANTICANCER RES, V17, P3201
[9]   HUMAN 72-KILODALTON TYPE-IV COLLAGENASE FORMS A COMPLEX WITH A TISSUE INHIBITOR OF METALLOPROTEASES DESIGNATED TIMP-2 [J].
GOLDBERG, GI ;
MARMER, BL ;
GRANT, GA ;
EISEN, AZ ;
WILHELM, S ;
HE, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8207-8211
[10]   Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A [J].
Higashi, S ;
Miyazaki, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) :10497-10504